Viral vector production in the integrity® iCELLis® single-use fixed-bed bioreactor, from bench-scale to industrial scale

被引：0
|
作者：
Alexandre Lennaertz
Shane Knowles
Jean-Christophe Drugmand
Jose Castillo
机构：
[1] ATMI LifeSciences,
来源：
BMC Proceedings | / 7卷 / Suppl 6期
关键词：
Packaging Cell Line; Gene Therapy Vector; rAAV Vector; Transfection Process; Adherent Cell Culture;
D O I：
10.1186/1753-6561-7-S6-P59
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Linear scalability of virus production in the integrity® iCELLis® single-use fixed-bed bioreactors from bench to industrial scale
    Shane Knowles
    Jean-Christophe Drugmand
    Nicolas Vertommen
    Jose Castillo
    [J]. BMC Proceedings, 7 (Suppl 6)
  • [2] Adeno-Associated Virus production using a disposable fixed-bed bioreactor from bench-scale to industrial scale
    Illingworth, C.
    Tordo, J.
    Duballet, M.
    Linden, M.
    Lennaertz, A.
    Drugmand, J. C.
    Castillo, J.
    [J]. HUMAN GENE THERAPY, 2013, 24 (12) : A99 - A99
  • [3] Adeno-Associated Virus Production Using a Disposable Fixed-Bed Bioreactor From Bench-Scale To Industrial Scale
    Illingworth, Crista
    Tordo, Julie
    Duballet, Martin
    Linden, Michael
    Lennaertz, A.
    Drugmand, J. C.
    Castillo, J.
    [J]. MOLECULAR THERAPY, 2014, 22 : S33 - S33
  • [4] Setting up a transfection-based rAAV production process in the Integrity iCellis™ single use fixed-bed bioreactor
    Pegel, A.
    Wegele, J.
    Kunz, M.
    Kueppers, C.
    Schulze, A.
    Roessner, A.
    Kress, D.
    Sonntag, F.
    Hoerer, M.
    [J]. HUMAN GENE THERAPY, 2013, 24 (12) : A96 - A96
  • [5] Scaling up the Lentiviral Vector Manufacturing Using iCELLis500 Clinical Scale Fixed-Bed Bioreactor
    Lipponen, Eevi M.
    Leinonen, Hanna M.
    Oruetxebarria, Igor
    Valkama, Anniina J.
    Malinen, Joonas
    Turkki, Vesa
    Laaksonen, Iina
    Pietikainen, Sanna
    Kayhty, Piia
    Heikura, Tommi
    Yla-Herttuala, Seppo
    Lesch, Hanna P.
    [J]. MOLECULAR THERAPY, 2017, 25 (05) : 224 - 224
  • [6] Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
    A J Valkama
    H M Leinonen
    E M Lipponen
    V Turkki
    J Malinen
    T Heikura
    S Ylä-Herttuala
    H P Lesch
    [J]. Gene Therapy, 2018, 25 : 39 - 46
  • [7] Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale
    Lesch, Hanna P.
    Heikkila, Kati M.
    Lipponen, Eevi M.
    Valonen, Piia
    Muller, Achim
    Rasanen, Eva
    Tuunanen, Tarja
    Hassinen, Minna M.
    Parker, Nigel
    Karhinen, Minna
    Shaw, Robert
    Yla-Herttuala, Seppo
    [J]. HUMAN GENE THERAPY, 2015, 26 (08) : 560 - 571
  • [8] Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
    Valkama, A. J.
    Leinonen, H. M.
    Lipponen, E. M.
    Turkki, V.
    Malinen, J.
    Heikura, T.
    Yla-Herttuala, S.
    Lesch, H. P.
    [J]. GENE THERAPY, 2018, 25 (01) : 39 - 46
  • [9] Mercury capture by an activated carbon in a fixed-bed bench-scale System
    Dunham, GE
    Miller, SJ
    Chang, R
    Bergman, P
    [J]. ENVIRONMENTAL PROGRESS, 1998, 17 (03): : 203 - 208
  • [10] iCELLis® fixed-bed technology provides an efficient scalable system for viral vector production
    Lesch, H. P.
    Valonen, P.
    Heikkila, K. M.
    Lipponen, E. M.
    Muller, A.
    Rasanen, E.
    Tuunanen, T.
    Malinen, J.
    Makkonen, K. E.
    Valkama, A.
    Heikura, T.
    Martikainen, A.
    Salonen, T.
    Nurminen, E. M.
    Hassinen, M. M.
    Karhinen, M.
    Parker, N. R.
    Shaw, R.
    Yla-Herttuala, S.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A25 - A25
12345